The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...

The resolution comes two months after the health regulator said there was no longer a shortage of Eli Lilly's weight-loss and ...

Utah’s Attorney General Derek Brown signed onto a letter along with attorneys general from 37 other states to ask the Food and Drug Administration to enforce the safety of weight loss drugs.

He has been critical of the boom in weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro. Kush Desai, a White House spokesman, said the order follows concerns about doctors ...

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...

For customers using a telehealth website to get cheaper versions of popular obesity drugs, the low prices ... to talk to one another during their weight-loss journeys. The Zappy chat was ...

Modern weight loss treatments have transformed how we approach obesity management, but they come with concerning side effects. The growing use of glucagon-like peptide-1 medications has ...

The "Hims and Hers" commercial railed against the weight loss industry and promoted the company's weight loss drug offerings as a less costly option compared to brand-name drugs. Eli Lilly’s ...